January 21, 2026 GDUFA IV Negotiation Meeting
On the negotiation front, the FDA and industry continue to feel each other out. While not many agreements have been finalized, the discussions appear, at least to this outsider, to be on a friendly give-and-take basis. The minutes of the January 21st meeting (here) outline the following topics. Invoice Timing The FDA agreed that it could […]
